Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Genentech, Inc. (Genentech or ‘the company’), a subsidiary of Roche Group is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company’s medicines include Activase, Boniva Tablets, Cotellic, Erivedge, Fuzeon, Gazyva, Hemlibra, Invirase, Klonopin, Lucentis, Actemra, Nutropin AQ, Ocrevus, Tamiflu, Pegasys, Rituxan, Rocephin, Tecentriq, Polivy, Rozlytrek, Valium, Xeloda and Zelboraf. The company offers its products with a focus on the areas of oncology, immunology, neuroscience, metabolism, ophthalmology, and infectious disease. Genentech manages its manufacturing facilities and distribution center in California and Oregon, the US. The company is headquartered in South San Francisco, California, the US.Scope
- Detailed information on Genentech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
- Intelligence on Genentech, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genentech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Genentech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genentech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Genentech, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Genentech, Inc.: Company Overview
- Genentech, Inc.: Overview and Key Facts
- Genentech, Inc.: Overview
- Genentech, Inc.: Key Facts
- Genentech, Inc.: Key Employees
- Genentech, Inc.: Major Products and Services
- Genentech, Inc.: Locations and Subsidiaries
- Genentech, Inc.: Key Competitors
- Genentech, Inc.: Company Analysis
- Genentech, Inc.: Business Description
- Genentech, Inc.: SWOT Analysis
- Genentech, Inc.: SWOT Overview
- Genentech, Inc.: Strengths
- Genentech, Inc.: Weaknesses
- Genentech, Inc.: Opportunities
- Genentech, Inc.: Threats
- Genentech, Inc.: Corporate Financial Deals Activity
- Genentech, Inc.: Financial Deals Overview
- Genentech, Inc.: Targets and Partners
- Genentech, Inc.: Top Deals 2019 - 2023YTD*
- Genentech, Inc.: Mergers and Acquisitions
- Genentech, Inc.: Partnership
- Genentech, Inc.: Recent Developments
- Genentech, Inc.: News and Events Summary
- Genentech, Inc.: Contracts
- Genentech, Inc.: Financial Deals
- Genentech, Inc.: Market Developments
- Genentech, Inc.: Research & Development
- Genentech, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
Table 1: Genentech, Inc.: Key Facts
Table 2: Genentech, Inc.: Key Employees
Table 3: Genentech, Inc.: Locations and Subsidiaries
Table 4: Genentech, Inc.: Key Competitors
Table 5: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genentech, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 7: Genentech, Inc.: Targets and Partners
Table 8: Genentech, Inc.: Top Deals 2019 - 2023YTD*
Table 9: Genentech, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 10: Genentech, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 11: Genentech, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 12: Genentech, Inc.: News and Events Summary
Table 13: Genentech, Inc.: Contracts
Table 14: Genentech, Inc.: Financial Deals
Table 15: Genentech, Inc.: Market Developments
Table 16: Genentech, Inc.: Research & Development
Table 17: Genentech, Inc.: Strategy and Operations
List of Figures
Figure 1: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Genentech, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Genentech, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 4: Genentech, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 5: Genentech, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
